Who
Chrystal Louis
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, TScan Therapeutics.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 May 2024
- Last trade
- 20 Jan 2026
- Last filed
- 22 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jan 2026filed 22 Jan 2026 | TCRX TScan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —420,000 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | TCRX TScan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —420,000 at $0.00 | filing |
| 3 Jan 2025filed 11 Feb 2025 | TCRX TScan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 1 May 2024filed 3 May 2024 | TCRX TScan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.